Praxis Precision Medicines, Inc. PRAX Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s net income?
- Praxis Precision Medicines, Inc. (PRAX) reported net income of -$92.56M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s net income changed year-over-year?
- Praxis Precision Medicines, Inc.'s net income decreased by 33.6% year-over-year, from -$69.3M to -$92.56M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s net income?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s net income has grown at a 16.1% compound annual growth rate (CAGR), from -$167.06M to -$303.27M.
- What does net income mean?
- The final profit or loss remaining after all expenses are paid.
- How do you interpret net income?
- Consistent positive net income indicates long-term viability, while persistent losses may signal a need for additional financing.
- How does net income compare across companies?
- The primary metric for assessing overall financial performance relative to industry benchmarks.